Consensus Ascletis Pharma Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 am EDT			5-day change	1st Jan Change
1.21 ^HKD	-0.82%		-3.97%	-17.12%

Apr. 03	Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus	MT
Apr. 03	Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42	CI

d068cdd6066.iswI-QFpwc6Wh3iiAQcUOng_4rLnb62WyQlT0RSbZQI.yYZqg1AEqq_Tsy72Nl16bSprleGxKt2hqkcVlVKiD3q5nWqjMlCTgtHrLQ~da0b9091cb15231df42e1f4171a58d3c

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.121 CNY

Average target price

2.752 CNY

Spread / Average Target

+145.59%

High Price Target

3.513 CNY

Spread / Highest target

+213.50%

Low Price Target

1.991 CNY

Spread / Lowest Target

+77.68%